reaffirms that there is no data to support it’s use for COVID-19.
Let that soak in. The pharmaceutical company that would stand to make tons of money if it was an actually effective treatment.
Guess the pharmaceutical manufacturer didn’t consult @FunkyMonk 🙄🙄
www.merck.com
Let that soak in. The pharmaceutical company that would stand to make tons of money if it was an actually effective treatment.
Guess the pharmaceutical manufacturer didn’t consult @FunkyMonk 🙄🙄
![www.merck.com](/proxy.php?image=https%3A%2F%2Fwww.merck.com%2Fwp-content%2Fuploads%2Fsites%2F124%2F2022%2F03%2FMerck.png&hash=0eb2cef6f6bbb9f936f6c5b954b0f565&return_error=1)
Merck Statement on Ivermectin use During the COVID-19 Pandemic - Merck.com
KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of all available and emerging studies of...
![www.merck.com](/proxy.php?image=https%3A%2F%2Fwww.merck.com%2Fwp-content%2Fthemes%2Fmhh-merck-mco-theme%2Fimages%2Ffavicon-32x32.png&hash=2fe17a4c6e54dd7efd60d221236e2588&return_error=1)